Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects

NCT02195635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interactions

Interventions

DRUG: Telotristat etiprate
DRUG: Octreotide acetate

Sponsor

Lexicon Pharmaceuticals